(NASDAQ: SENS) Senseonics Holdings's forecast annual revenue growth rate of 57.13% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.07%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.48%.
Senseonics Holdings's revenue in 2026 is $35,257,000.On average, 10 Wall Street analysts forecast SENS's revenue for 2026 to be $2,506,562,124, with the lowest SENS revenue forecast at $2,292,363,174, and the highest SENS revenue forecast at $2,710,485,539. On average, 10 Wall Street analysts forecast SENS's revenue for 2027 to be $3,987,993,471, with the lowest SENS revenue forecast at $3,127,438,330, and the highest SENS revenue forecast at $5,561,319,843.
In 2028, SENS is forecast to generate $5,811,107,230 in revenue, with the lowest revenue forecast at $4,682,886,943 and the highest revenue forecast at $7,007,413,376.